These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7840580)

  • 1. Pharmacokinetics of ceftriaxone in patients with typhoid fever.
    Acharya G; Crevoisier C; Butler T; Ho M; Tiwari M; Stoeckel K; Bradley CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2415-8. PubMed ID: 7840580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.
    Islam A; Butler T; Kabir I; Alam NH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1572-5. PubMed ID: 8215265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial.
    Lasserre R; Sangalang RP; Santiago L
    J Antimicrob Chemother; 1991 Nov; 28(5):765-72. PubMed ID: 1778879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol.
    Acharya G; Butler T; Ho M; Sharma PR; Tiwari M; Adhikari RK; Khagda JB; Pokhrel B; Pathak UN
    Am J Trop Med Hyg; 1995 Feb; 52(2):162-5. PubMed ID: 7872445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol.
    Tatli MM; Aktas G; Kosecik M; Yilmaz A
    Int J Antimicrob Agents; 2003 Apr; 21(4):350-3. PubMed ID: 12672582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in children.
    Moosa A; Rubidge CJ
    Pediatr Infect Dis J; 1989 Oct; 8(10):696-9. PubMed ID: 2812914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of ceftriaxone in the first three month of life].
    Rondanelli R; Regazzi MB; Stronati M; Calvi M; Lombardi G; Rondini G
    Pediatr Med Chir; 1992; 14(1):55-9. PubMed ID: 1579518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of typhoid fever for three days with ceftriaxone].
    Lasserre R
    Bull Soc Pathol Exot; 1990; 83(4):468-72. PubMed ID: 2286000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol.
    Islam A; Butler T; Nath SK; Alam NH; Stoeckel K; Houser HB; Smith AL
    J Infect Dis; 1988 Oct; 158(4):742-7. PubMed ID: 3171225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.
    Frenck RW; Nakhla I; Sultan Y; Bassily SB; Girgis YF; David J; Butler TC; Girgis NI; Morsy M
    Clin Infect Dis; 2000 Nov; 31(5):1134-8. PubMed ID: 11073741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone therapy in bacteremic typhoid fever.
    Ti TY; Monteiro EH; Lam S; Lee HS
    Antimicrob Agents Chemother; 1985 Oct; 28(4):540-3. PubMed ID: 4073877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
    Dutta P; Mitra U; Dutta S; De A; Chatterjee MK; Bhattacharya SK
    Indian J Med Res; 2001 Jun; 113():210-3. PubMed ID: 11816954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftriaxone in humans.
    Patel IH; Chen S; Parsonnet M; Hackman MR; Brooks MA; Konikoff J; Kaplan SA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and dosage regimen of ceftriaxone in E. coli lipopolysaccharide induced fever in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    J Vet Sci; 2005 Jun; 6(2):147-50. PubMed ID: 15933435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    Vet Res Commun; 2004 May; 28(4):331-8. PubMed ID: 15222737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftriaxone in liver-transplant recipients.
    Toth A; Abdallah HY; Venkataramanan R; Teperman L; Halsf G; Rabinovitch M; Burckart GJ; Starzl TE
    J Clin Pharmacol; 1991 Aug; 31(8):722-8. PubMed ID: 1880231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.
    Smith MD; Duong NM; Hoa NT; Wain J; Ha HD; Diep TS; Day NP; Hien TT; White NJ
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1716-20. PubMed ID: 7986000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.
    Zhu Z; Wang AX; Li Y
    Chemotherapy; 1997; 43(3):218-26. PubMed ID: 9142464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.